Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by McLaughlin, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McLaughlin, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 13:499-500, 2002
© 2002 European Society for Medical Oncology

Editorial

Profiling: "Editorial on ‘Survival after progression in patients with follicular lymphoma: analysis of prognostic factors’ ", by S. Montoto et al. (Ann Oncol 2002; 13: 523–530)

P. McLaughlin

Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Profiling is not just a telemarketing or law enforcement tool. As physicians, we profile our patients so that we can make intelligent management recommendations. The paper by Montoto et al. [1] can help us do our job better for patients with recurrent follicular lymphoma.

Most prognostic models pertain to previously untreated patients. Such analyses focus on disease and host features, but do not take into account the impact of therapy. A model such as the International Prognostic Index (IPI) [2] for aggressive lymphoma is highly . . . [Full Text of this Article]

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?